Eurofins Technologies

Eurofins Technologies

Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test kits and lab consumables in the fields of bioanalytical testing for the food, feed, environmental, biopharma, and clinical industries. The company offers a broad range of product test kits for Pathogens ...
Productos Covid-19
Close

Covid-19 Eurofins Technologies

Laboratorio clínico

SARS-CoV-2 Assay
INgezim COVID RBD-DR

INgezim COVID RBD-DR is a CE-marked double recognition enzyme-linked immunosorbent assay for detecting antibodies specific to S (RBD) of SARS-CoV-2 in human serum samples. The highly sensitive test is particularly recommended for the early detection of SARS-CoV-2 specific antibodies as it favors the detection of IgM.
Mas detalles

PRUEBA SARS-COV-2
INgezim COVID 19 SPIKE CROM

INgezim COVID 19 SPIKE CROM es un ensayo inmunocromatográfico de doble reconocimiento para la determinación cualitativa de anticuerpos totales específicos de la proteína S del SARS-CoV-2 en individuos vacunados, en muestras de suero y sangre.
Mas detalles

SARS-CoV-2 RT-PCR Assays
GSD NovaType Select SARS-CoV-2 Assay Family

GSD NovaType Select is a group of RT-PCR assays to discriminate variants of the SARS-CoV-2 virus. The assay family provides the opportunity to assemble a customized RT-PCR assay mutation panel from a basis kit including the enzyme mastermix, and a range of mutation specific sets, including primer, probes and controls. The research use only (RUO) Select assays detect the following mutations: K417N, K417T, L452R, T478K, E484K, P681R and P618H.
Mas detalles

PRUEBA RT-PCR PARA SARS-COV-2
GSD NovaType III SARS-CoV-2

La GSD NovaType III SARS-CoV-2 RT-PCR está desarrollada para la detección rápida de variantes de preocupación del SARS-CoV-2, incluidas B.1.427 / B.1.429 (Epsilon) / B.1.617.2 (Delta), B.1.617 .1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).
Mas detalles

ENSAYO RT-PCR MULTIPLEXADO PARA SARS-COV-2
GSD NovaPrime Plus SARS-CoV-2

El NovaPrime Plus SARS-CoV-2 con marca CE está diseñado para la detección cualitativa del SARS-CoV-2 y la discriminación simultánea de los linajes B.1.1.7 (Alpha), B.1.351 (Beta) y B.1.1.248 (P.1) (Gamma) en una reacción.
Mas detalles

SARS-CoV-2 RT-PCR Assay
GSD NovaType II SARS-CoV-2

The GSD NovaType II SARS-CoV-2 Real-Time RT-PCR assay allows for the identification of relevant mutations associated with SARS-CoV-2 variants: B.1.1.7 (UK), B.1.351 (South Africa), and B.1.1.28 (P.1) (Brazil). The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR kit.
Mas detalles

SARS-CoV-2 Ag Rapid Test (Nasal Swab)
GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab)

The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigens present in nasopharyngeal swab specimen. The CE-IVD labeled rapid test detects SARS-CoV-2 antigens in 15 minutes with a diagnostic sensitivity of 92.6% and diagnostic specificity of 98.6%.
Mas detalles

SARS-CoV-2 IgG ELISA Kit
NovaLisa SARS-CoV-2 IgG

The NovaLisa SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The CE-IVD marked assay demonstrates high sensitivity with antibodies detected in all tested samples from patients PCR positive for SARS-CoV-2 12 days after symptom onset (100% sensitivity in this patient group), and a specificity of >98%.
Mas detalles

PRUEBA DE SARS-COV-2
GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR

La prueba RT-PCR GSD NovaPrime® SARS-CoV-2 (COVID-19) fue diseñada para la determinación cualitativa del ARN genómico del SARS-CoV-2 (síndrome respiratorio agudo severo por el coronavirus 2) extraído de varios tipos de muestras respiratorias humanas.
Mas detalles

PRUEBA DE ANTICUERPOS CONTRA COVID-19
INgezim COVID 19 DR

El ensayo inmunoabsorbente ligado a enzimas de reconocimiento dual (ELISA), puede detectar semicuantitativamente anticuerpos específicos contra la proteína N del virus SARSCoV-2 en una sola muestra de suero o plasma humano.
Mas detalles

SARS-CoV-2 (COVID-19) Antibody Test
INgezim COVID 19 CROM

The INgezim COVID 19 CROM is a dual recognition immunochromatographic assay capable of detecting specific COVID-19 (SARS-CoV-2) antibodies (IgG, IgA, and IgM) in serum and blood samples. The test is able to detect antibodies specific to SARS-CoV-2 in 94.5% of cases from day 19. There is no cross-reactivity with antibodies specific to other coronaviruses or agents related to human respiratory illnesses.
Mas detalles

Actualizado

PRUEBA SARS-COV-2
INgezim COVID 19 SPIKE CROM

INgezim COVID 19 SPIKE CROM es un ensayo inmunocromatográfico de doble reconocimiento para la determinación cualitativa de anticuerpos totales específicos de la proteína S del SARS-CoV-2 en individuos vacunados, en muestras de suero y sangre.
Mas detalles

SARS-CoV-2 Assay
INgezim COVID RBD-DR

INgezim COVID RBD-DR is a CE-marked double recognition enzyme-linked immunosorbent assay for detecting antibodies specific to S (RBD) of SARS-CoV-2 in human serum samples. The highly sensitive test is particularly recommended for the early detection of SARS-CoV-2 specific antibodies as it favors the detection of IgM.
Mas detalles

ENSAYO RT-PCR MULTIPLEXADO PARA SARS-COV-2
GSD NovaPrime Plus SARS-CoV-2

El NovaPrime Plus SARS-CoV-2 con marca CE está diseñado para la detección cualitativa del SARS-CoV-2 y la discriminación simultánea de los linajes B.1.1.7 (Alpha), B.1.351 (Beta) y B.1.1.248 (P.1) (Gamma) en una reacción.
Mas detalles

Laboratorio clínico

PRUEBA SARS-COV-2
INgezim COVID 19 SPIKE CROM

INgezim COVID 19 SPIKE CROM es un ensayo inmunocromatográfico de doble reconocimiento para la determinación cualitativa de anticuerpos totales específicos de la proteína S del SARS-CoV-2 en individuos vacunados, en muestras de suero y sangre.
Mas detalles

SARS-CoV-2 Assay
INgezim COVID RBD-DR

INgezim COVID RBD-DR is a CE-marked double recognition enzyme-linked immunosorbent assay for detecting antibodies specific to S (RBD) of SARS-CoV-2 in human serum samples. The highly sensitive test is particularly recommended for the early detection of SARS-CoV-2 specific antibodies as it favors the detection of IgM.
Mas detalles

ENSAYO RT-PCR MULTIPLEXADO PARA SARS-COV-2
GSD NovaPrime Plus SARS-CoV-2

El NovaPrime Plus SARS-CoV-2 con marca CE está diseñado para la detección cualitativa del SARS-CoV-2 y la discriminación simultánea de los linajes B.1.1.7 (Alpha), B.1.351 (Beta) y B.1.1.248 (P.1) (Gamma) en una reacción.
Mas detalles

PRUEBA RT-PCR PARA SARS-COV-2
GSD NovaType III SARS-CoV-2

La GSD NovaType III SARS-CoV-2 RT-PCR está desarrollada para la detección rápida de variantes de preocupación del SARS-CoV-2, incluidas B.1.427 / B.1.429 (Epsilon) / B.1.617.2 (Delta), B.1.617 .1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).
Mas detalles

SARS-CoV-2 RT-PCR Assays
GSD NovaType Select SARS-CoV-2 Assay Family

GSD NovaType Select is a group of RT-PCR assays to discriminate variants of the SARS-CoV-2 virus. The assay family provides the opportunity to assemble a customized RT-PCR assay mutation panel from a basis kit including the enzyme mastermix, and a range of mutation specific sets, including primer, probes and controls. The research use only (RUO) Select assays detect the following mutations: K417N, K417T, L452R, T478K, E484K, P681R and P618H.
Mas detalles

SARS-CoV-2 IgG ELISA Kit
NovaLisa SARS-CoV-2 IgG

The NovaLisa SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The CE-IVD marked assay demonstrates high sensitivity with antibodies detected in all tested samples from patients PCR positive for SARS-CoV-2 12 days after symptom onset (100% sensitivity in this patient group), and a specificity of >98%.
Mas detalles

SARS-CoV-2 Ag Rapid Test (Nasal Swab)
GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab)

The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigens present in nasopharyngeal swab specimen. The CE-IVD labeled rapid test detects SARS-CoV-2 antigens in 15 minutes with a diagnostic sensitivity of 92.6% and diagnostic specificity of 98.6%.
Mas detalles

SARS-CoV-2 RT-PCR Assay
GSD NovaType II SARS-CoV-2

The GSD NovaType II SARS-CoV-2 Real-Time RT-PCR assay allows for the identification of relevant mutations associated with SARS-CoV-2 variants: B.1.1.7 (UK), B.1.351 (South Africa), and B.1.1.28 (P.1) (Brazil). The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR kit.
Mas detalles

SARS-CoV-2 (COVID-19) Antibody Test
INgezim COVID 19 CROM

The INgezim COVID 19 CROM is a dual recognition immunochromatographic assay capable of detecting specific COVID-19 (SARS-CoV-2) antibodies (IgG, IgA, and IgM) in serum and blood samples. The test is able to detect antibodies specific to SARS-CoV-2 in 94.5% of cases from day 19. There is no cross-reactivity with antibodies specific to other coronaviruses or agents related to human respiratory illnesses.
Mas detalles

PRUEBA DE ANTICUERPOS CONTRA COVID-19
INgezim COVID 19 DR

El ensayo inmunoabsorbente ligado a enzimas de reconocimiento dual (ELISA), puede detectar semicuantitativamente anticuerpos específicos contra la proteína N del virus SARSCoV-2 en una sola muestra de suero o plasma humano.
Mas detalles

PRUEBA DE SARS-COV-2
GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR

La prueba RT-PCR GSD NovaPrime® SARS-CoV-2 (COVID-19) fue diseñada para la determinación cualitativa del ARN genómico del SARS-CoV-2 (síndrome respiratorio agudo severo por el coronavirus 2) extraído de varios tipos de muestras respiratorias humanas.
Mas detalles
Derecho de autor © 2000-2024 TradeMed.com. Todos los derechos reservados. | Términos y condiciones